Log In
Print
BCIQ
Print
Print this Print this
 

CB-839

  Manage Alerts
Collapse Summary General Information
Company Calithera Biosciences Inc.
DescriptionOral selective glutaminase (GLS) inhibitor
Molecular Target Glutaminase (GLS)
Mechanism of ActionGlutaminase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today